Entrada Therapeutics, Inc. · NASDAQ:TRDA
Doshi Dipal had 8,724 Entrada Therapeutics, Inc. shares withheld for tax (Form 4)
Traded Sep 2, 2026 · Filed Sep 3, 2026
On Sep 2, 2026, Doshi Dipal (Director, CEO) had 8,724 Entrada Therapeutics, Inc. shares withheld for tax at US$7.14 for US$62,289, leaving 517,290 shares. Filed Sep 3, 2026 (Form 4).
- Withheld for tax
- 8,724 shares
- Price
- US$7.14
- Value
- US$62,289
- Holding after
- 517,290 shares
- Trading plan
- No
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Shares withheld for tax | 8,724 | US$7.14 | 517,290 | Direct |
Source
Related
- Entrada Therapeutics, Inc.
- Doshi Dipal
- Entrada Therapeutics, Inc. shareholders
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026